TACE Plus HAIC Combined With Regorafenib for Liver Metastasis of Colorectal Cancer Refractory to Standard Treatment Regimens

NCT06071052 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Liver Metastasis Colon Cancer

Interventions

COMBINATION_PRODUCT: TACE and HAIC Combined With Regorafenib

Sponsor

First Affiliated Hospital, Sun Yat-Sen University